Terri B. Sebree
2017
In 2017, Terri B. Sebree earned a total compensation of $1.6M as President at Zynerba Pharmaceuticals, a 135% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $223,762 |
|---|---|
| Option Awards | $938,713 |
| Salary | $425,000 |
| Other | $17,959 |
| Total | $1,605,434 |
Sebree received $938.7K in option awards, accounting for 58% of the total pay in 2017.
Sebree also received $223.8K in non-equity incentive plan, $425K in salary and $18K in other compensation.
Rankings
In 2017, Terri B. Sebree's compensation ranked 6,628th out of 14,666 executives tracked by ExecPay. In other words, Sebree earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,628 out of 14,666 | 55th |
Division Manufacturing | 2,451 out of 5,772 | 58th |
Major group Chemicals And Allied Products | 788 out of 2,075 | 62nd |
Industry group Drugs | 608 out of 1,731 | 65th |
Industry Pharmaceutical Preparations | 480 out of 1,333 | 64th |
Source: SEC filing on April 23, 2018.
Sebree's colleagues
We found two more compensation records of executives who worked with Terri B. Sebree at Zynerba Pharmaceuticals in 2017.
News
Zynerba Pharmaceuticals CEO Armando Anido's 2022 pay slips 15% to $1.9M
April 21, 2023
Zynerba Pharmaceuticals CEO Armando Anido's 2021 pay jumps 49% to $2.2M
April 25, 2022
Zynerba Pharmaceuticals CEO Armando Anido's 2020 pay rises 8% to $1.5M
April 21, 2021
Zynerba Pharmaceuticals CEO Armando Anido's 2019 pay falls 32% to $1.4M
April 23, 2020
Zynerba Pharmaceuticals CEO Armando Anido's 2018 pay slips 18% to $2M
April 25, 2019